The adaptor protein APPL2 inhibits insulin-stimulated glucose uptake by interacting with TBC1D1 in skeletal muscle

Diabetes

Volumn 63, Issue 11, 2014, Pages 3748-3758

  Cheng, Kenneth K Y ^a,b   Zhu, Weidong ^b   Chen, Bin ^b   Wang, Yu ^a,b   Wu, Donghai ^c   Sweeney, Gary ^d   Wang, Baile ^a,b   Lam, Karen S L ^a,b   Xu, Aimin ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^d YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN APPL1; ALANINE; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN TBC1D1; RAB PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG; APPL1 PROTEIN, HUMAN; APPL1 PROTEIN, MOUSE; APPL2 PROTEIN, HUMAN; GLUCOSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GLUCOSE TRANSPORT; MOUSE; MYOTUBE; NONHUMAN; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SKELETAL MUSCLE; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; TRANSGENIC MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; GLUCOSE; HUMANS; IMMUNOPRECIPITATION; INSULIN; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHOSPHORYLATION; RNA INTERFERENCE;

EID: 84908657614     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0337     Document Type: Article

References (42)

1. Bogan JS. Regulation of glucose transporter translocation in health and diabetes. Annu Rev Biochem 2012;81:507-532
2. Ryder JW, Yang J, Galuska D, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49:647-654
3. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998;101:2377-2386
4. Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6:924-928
5. Gibbs EM, Stock JL, McCoid SC, et al. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 1995;95:1512-1518
6. Sakamoto K, Holman GD. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am J Physiol Endocrinol Metab 2008;295:E29-E37
7. Cheng KK, Lam KS, Wang B, Xu A. Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin. Best Pract Res Clin Endocrinol Metab 2014;28:3-13
8. Cheng KK, Lam KS, Wu D, et al. APPL1 potentiates insulin secretion in pancreatic b cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice. Proc Natl Acad Sci U S A 2012;109:8919-8924
9. Wang Y, Cheng KK, Lam KS, et al. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice. Diabetes 2011;60: 3044-3054
10. Park M, Wu D, Park T, et al. APPL1 transgenic mice are protected from high-fat diet-induced cardiac dysfunction. Am J Physiol Endocrinol Metab 2013; 305:E795-E804
11. Cheng KK, Iglesias MA, Lam KS, et al. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab 2009;9:417-427
12. Cheng KK, Lam KS, Wang Y, et al. TRAF6-mediated ubiquitination of APPL1 enhances hepatic actions of insulin by promoting the membrane translocation of Akt. Biochem J 2013;455:207-216
13. Mao X, Kikani CK, Riojas RA, et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 2006;8:516-523
14. Schenck A, Goto-Silva L, Collinet C, et al. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 2008;133:486-497
15. Miaczynska M, Christoforidis S, Giner A, et al. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 2004;116:445-456
16. Wang C, Xin X, Xiang R, et al. Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J Biol Chem 2009;284:31608-31615
17. King GJ, Stöckli J, Hu SH, et al. Membrane curvature protein exhibits interdomain flexibility and binds a small GTPase. J Biol Chem 2012;287:40996-41006
18. Li J, Mao X, Dong LQ, Liu F, Tong L. Crystal structures of the BAR-PH and PTB domains of human APPL1. Structure 2007;15:525-533
19. Zhu G, Chen J, Liu J, et al. Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5. EMBO J 2007;26:3484-3493
20. Vu V, Bui P, Eguchi M, Xu A, Sweeney G. Globular adiponectin induces LKB1/AMPK-dependent glucose uptake via actin cytoskeleton remodeling. J Mol Endocrinol 2013;51:155-165
21. Zhang X, Xu A, Chung SK, et al. Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 2011;60: 486-495
22. Wang Q, Khayat Z, Kishi K, Ebina Y, Klip A. GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS Lett 1998; 427:193-197
23. Wang Y, Xu LY, Lam KS, Lu G, Cooper GJ, Xu A. Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin. Proteomics 2006;6:3862-3870
24. Cleasby ME, Lau Q, Polkinghorne E, et al. The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway. J Endocrinol 2011;210:81-92
25. Taylor EB, An D, Kramer HF, et al. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 2008;283:9787-9796
26. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 2008;409:449-459
27. Peck GR, Chavez JA, Roach WG, et al. Insulin-stimulated phosphorylation of the Rab GTPase-activating protein TBC1D1 regulates GLUT4 translocation. J Biol Chem 2009;284:30016-30023
28. Roach WG, Chavez JA, Mîinea CP, Lienhard GE. Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. Biochem J 2007;403:353-358
29. Yang L, Lin HK, Altuwaijri S, Xie S, Wang L, Chang C. APPL suppresses androgen receptor transactivation via potentiating Akt activity. J Biol Chem 2003; 278:16820-16827
30. Nechamen CA, Thomas RM, Dias JA. APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. Mol Cell Endocrinol 2007; 260-262:93-99
31. Chial HJ, Wu R, Ustach CV, McPhail LC, Mobley WC, Chen YQ. Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides. Traffic 2008;9:215-229
32. Erdmann KS, Mao Y, McCrea HJ, et al. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev Cell 2007;13:377-390
33. Szekeres F, Chadt A, Tom RZ, et al. The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am J Physiol Endocrinol Metab 2012;303:E524-E533
34. Lansey MN, Walker NN, Hargett SR, Stevens JR, Keller SR. Deletion of Rab GAP AS160 modifies glucose uptake and GLUT4 translocation in primary skeletal muscles and adipocytes and impairs glucose homeostasis. Am J Physiol Endocrinol Metab 2012;303:E1273-E1286
35. Geraghty KM, Chen S, Harthill JE, et al. Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. Biochem J 2007;407:231-241
36. Sano H, Kane S, Sano E, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003;278: 14599-14602
37. Thong FS, Bilan PJ, Klip A. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007;56:414-423
38. Zeigerer A, McBrayer MK, McGraw TE. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 2004;15:4406-4415
39. Chen S, Wasserman DH, MacKintosh C, Sakamoto K. Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 2011;13:68-79
40. Vichaiwong K, Purohit S, An D, et al. Contraction regulates site-specific phosphorylation of TBC1D1 in skeletal muscle. Biochem J 2010;431:311-320
41. Pehmøller C, Treebak JT, Birk JB, et al. Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2009;297:E665-E675
42. Frøsig C, Pehmøller C, Birk JB, Richter EA, Wojtaszewski JF. Exerciseinduced TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle. J Physiol 2010;588:4539-4548